SMARCA5 and acute myeloid leukemia: Thus, the deletion of the SMARCA5 gene completely impaired leukemic cell proliferation in most of the AML cell lines, while in K562 cells it was tolerated albeit under markedly lower proliferation activity, which allowed us to study it in more detail.